1-5 of 5
Karim Saad Iskander
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Carfilzomib, Pomalidomide and Dexamethasone (KPd) in Patients with Multiple Myeloma Refractory to Bortezomib and Lenalidomide. the EMN011 Trial

Pieter Sonneveld, MDPhD, Sonja Zweegman, MDPhD, Michele Cavo, MD, Kazem Nasserinejad, PhD, Rosella Troia, Ludek Pour, MD, Sandra Croockewit, MD, Paolo Corradini, MD, Francesca Patriarca, MD, Kalung Wu, MD, Jolanda Droogendijk, MD, Annemiek Broyl, MD PhD, Monique C Minnema, MD PhD, Bruno Costa, Karim Saad Iskander, MD, Mario Boccadoro, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 801.
https://doi.org/10.1182/blood-2018-99-114029
Published: 2018
Journal Articles

Demographic and Clinical Characteristics of Multiple Myeloma (MM) Patients Treated with Carfilzomib-Based Regimens in a Real World Setting

Christopher Kim, PhD, Winifred Werther, Karim Saad Iskander, Michael Gruber, Khalid Mezzi, MD MBA
Journal: Blood
Blood (2017) 130 (Supplement 1): 5441.
https://doi.org/10.1182/blood.V130.Suppl_1.5441.5441
Published: 2017
Journal Articles

Carfilzomib Combined with Thalidomide and Low-Dose Dexamethasone for Remission Induction and Consolidation in Newly Diagnosed, Transplant Eligible Patients with Multiple Myeloma: The Carthadex Trial

Ruth Wester, Bronno van der Holt, Emelie Asselbergs, Sonja Zweegman, MD PhD, Marie José Kersten, MD, Edo Vellenga, MD, Marinus van Marwijk Kooij, MD PhD, Okke de Weerdt, MD, Monique C Minnema, Sarah Lonergan, Antonio Palumbo, MD, Henk M Lokhorst, Annemiek Broyl, MD PhD, Karim Saad Iskander, Pieter Sonneveld, MDPhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3141.
https://doi.org/10.1182/blood.V130.Suppl_1.3141.3141
Published: 2017
Journal Articles

Relapsed or Refractory Multiple Myeloma Patients Treated with Second-Line Carfilzomib and Categorized By Prior Exposure to Bortezomib: A Subgroup Analysis of the Randomized Phase 3 Aspire and Endeavor Trials

Maria-Victoria Mateos, Hartmut Goldschmidt, MD, Jesus F San Miguel, MD PhD, Joseph Mikhael, MD, Lifen Zhou, Mihaela Obreja, Julie Blaedel, Karim Saad Iskander, Xavier Leleu, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1840.
https://doi.org/10.1182/blood.V130.Suppl_1.1840.1840
Published: 2017
Journal Articles

Superior Efficacy of Carfilzomib and Dexamethasone (Kd56) Vs Bortezomib and Dexamethasone (Vd) in Multiple Myeloma (MM) Patients with Moderate or Serious Renal Failure: A Subgroup Analysis of the Phase 3 Endeavor Study

Meletios A. Dimopoulos, David Siegel, MD PhD, Darrell J. White, MD, Ralph V. Boccia, Zhao Yang, Amy S. Kimball, Karim Saad Iskander, Khalid Mezzi, MD MBA, Heinz Ludwig, MD, Ruben Niesvizky, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1845.
https://doi.org/10.1182/blood.V130.Suppl_1.1845.1845
Published: 2017